2026 WA Award
The 2026 WA Pearcey Entrepreneur Award was presented to Professor Girish Dwivedi, at the 35th WAITTA Incite Awards in Perth on Friday 17th July 2026. Professor Dwivedi has combined bold entrepreneurial risk-taking with a lasting commitment to building Western Australia's medical technology ecosystem.
Professor Dwivedi co-founded both Lubdub AI and CAD Spectral Technologies and was a founding employee of Artrya Ltd back in 2018 when AI-driven cardiac diagnostics were in their infancy. After Artrya was listed on the ASX, Professor Dwivedi was appointed as their Chief Scientific Officer, and since then, Artrya has grown to a value of over A$900 million.
In parallel, Professor Dwivedi is a practitioner, academic and advisor. His many roles include Clinical Lead for Innovation at South Metropolitan Health Service), Professor of Cardiology at UWA with more than 30 researchers, and a contributor to many national advisories on AI and health policy.
Having secured over A$33 million in research funding, Professor Dwivedi continues developing new platforms like ORVA and Health Ledger (a project finalist in the 35th INCITE Awards) proving that globally relevant innovation, and the people who drive it, can come from WA.
Celia Jordaan, Chief Judge, INCITE Awards, commented,
Professor Girish Dwivedi embodies the entrepreneurial leadership the Pearcey Awards were created to recognise. What distinguished Professor Dwivedi was not a single successful venture, but his remarkable ability to repeatedly identify opportunity, take calculated risks and transform world-leading Australian research into globally significant health technology companies.
Throughout his entrepreneurial journey, he has successfully brought together researchers, clinicians, investors and industry to create ventures that are improving healthcare, advancing artificial intelligence and demonstrating that globally competitive innovation can originate in Western Australia. Beyond commercial success, he has strengthened our innovation ecosystem through leadership, mentorship and collaboration, creating a legacy that extends well beyond any individual company.
Professor Dwivedi is an outstanding representative of Western Australia's entrepreneurial capability and a thoroughly deserving recipient of the 2026 WA Pearcey Entrepreneur Award.
In accepting the Award, Professor Dwivedi said,
Devising devices and products that improve outcomes for my patients has been deeply rewarding, but working with the incredible young students in my team has been the most enjoyable part of all.
Professor Girish Dwivedi
Professor Girish Dwivedi is a cardiologist, academic leader and health technology entrepreneur.
He is renowned for translating cardiovascular research into clinically useful and commercially scalable technologies across artificial intelligence (AI), digital health and diagnostic equipment. His work combines academic medicine, clinical practice, entrepreneurship and health technology development.
Alongside senior academic and clinical roles, he has helped establish, advise or lead several medical technology ventures, including Artrya Ltd, Lubdub, CAD Spectral Technologies and ProGenis Medical.
History
Professor Girish Dwivedi completed a PhD in non-invasive cardiac imaging at the University of Manchester in 2010, with research into heart conditions and cardiac blood flow.
Before moving to Western Australia, he worked in Canada as a Clinician Scientist and Consultant Cardiologist at the University of Ottawa Heart Institute. During this period, he developed expertise in advanced cardiovascular imaging and held recognition including a Banting Post-Doctoral Fellowship and a Clinical Chair in Imaging.
In 2017, Professor Dwivedi joined The University of Western Australia (UWA) and Fiona Stanley Hospital in Perth, combining clinical cardiology, academic research, and commercialisation of health technology.
His professional background includes advanced accreditation across cardiac CT, echocardiography, cardiac magnetic resonance and nuclear cardiology, including Positron Emission Tomography (PET).
Commercial
Professor Dwivedi’s ventures bring together clinical expertise, imaging science and data-driven technologies to produce practical diagnostic products. These include AI-enabled cardiac imaging, portable biosensing, digital ECG solutions, patch-based echocardiography and retinal imaging for vascular risk assessment.
Professor Dwivedi's roles have been broad, including founder and senior executive positions, scientific leadership, clinical validation, regulatory translation and engagement with commercial partners.
At Artrya Ltd, he was involved from the company’s early formation and has served as Chief Scientific Officer since 2022. Artrya develops AI technology for detecting and assessing coronary artery disease using cardiac CT imaging, and has progressed through clinical validation, intellectual property development, public listing on the ASX and international product accreditation.
He is a co-founder and Director of Lubdub AI, a cardiovascular digital health venture focused on remote and point-of-need heart assessment.
He is also co-founded CAD Spectral Technologies, which applies retinal imaging and AI to cardiovascular risk assessment.
Research
Professor Dwivedi currently holds several senior academic and research appointments across Western Australia’s cardiovascular research ecosystem, including at the University of Western Australia (UWA), Victor Chang Cardiac Research Institute (VCCRI) and Harry Perkins Institute of Medical Research (HPIMR).
His current positions include Professor of Cardiology at UWA and Fiona Stanley Hospital, Professor of Cardiology and Head of the CardioInnovate Translation Lab WA at VCCRI, Director of the Cardiometabolic Clinic at the Centre for Cardiometabolic Health and Research at Fiona Stanley Hospital and HPIMR, Adjunct Professor of Cardiology at the University of Sydney, Clinical Lead for Innovation at South Metropolitan Health Service and Joint Head of the Cardiovascular Disease and Diabetes Program at HPIMR.
He has supervised and mentored more than 30 doctoral and postdoctoral researchers and currently leads multidisciplinary teams working across cardiovascular research, AI and digital health.
For his research, he has secured more than A$33 million in competitive funding. His work has supported translational research programs and emerging technology initiatives including ORVA, Health Ledger and the Leptos project.
Industry
Across his ventures and leadership roles, Professor Dwivedi has contributed to the development of AI-enabled cardiovascular diagnostics, digital health platforms and multidisciplinary innovation programs. This has included providing strategic and clinical translation support to ProGenis Medical.
As an author, Professor Dwivedi has published more than 300 papers and written chapters for prestigious books in cardiology. He is also an ad hoc peer reviewer for several high-impact cardiology journals.
Professor Dwivedi has held many national and international advisory roles across AI in healthcare, cardiovascular medicine and research strategy. These roles have supported collaboration between clinicians, researchers, engineers, data scientists, industry, investors and government stakeholders.
His recognition includes South Metropolitan Health Service Researcher of the Year and selection as a WA Innovator of the Year finalist.
